It is a pharma private limited company based in Paravada, Andhra Pradesh, India, established in 2014.
2014 | Paravada, Andhra Pradesh, India | ActiveAverx Drugs Private Limited, a active private limited company, was established on 26 August 2014 in Paravada, Andhra Pradesh, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24100AP2014PTC095163. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.91 Cr.
It upholds a compliant status. Its leadership includes Dhana Lakshmi Tirupathi (Director), Nagasekhar Ramineni (Managing Director), Srinivas Ramineni (Additional Director). Past directors included Rama Veera Venkata Siva Prasad Nagireddy, Nagasekhar Ramineni, Uma Rani Burra. It holds ₹7.48 Cr open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Plot No 27A, 32A And 27A31 Denotified Area, Lalamkoduru, Rambilli, Atchuthapuram, Paravada, Andhra Pradesh, 531019.
U24100AP2014PTC095163
095163
26 August 2014
₹10.00 Cr
₹9.91 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Averx Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhana Lakshmi Tirupathi | Director | 25 Apr 2015 | Current |
| Nagasekhar Ramineni | Managing Director | 27 Mar 2019 | Current |
| Srinivas Ramineni | Additional Director | 29 Jan 2024 | Current |
| Vns Gopal Raju Kurapati | Director | 26 Aug 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Apr 2021 | Past |
| Pramod Abcsdd | Director | 23 May 2024 | Past |
| Pramod Abcsdd | Director | 11 Jul 2015 | Past |
| Pramod Abcsdd | Director | 27 Apr 2024 | Past |
| Pramod Abcsdd | Managing Director | 10 Jul 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Averx Drugs Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 209.54% increase. The company also saw a substantial improvement in profitability, with a 69.93% increase in profit. The company's net worth Soared by an impressive increase of 67.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Averx Drugs had a promoter holding of 96.01% and a public holding of 3.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹74,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Sep 2018 | Others | ₹2.13 Cr | Open |
| 31 Aug 2016 | Others | ₹5.35 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Averx Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Averx Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Averx Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Srinivas Ramineni was appointed as a Additional Director was appointed as a Additional Director on 29 Jan 2024 & has been associated with this company since 1 year 10 months . was documented.
The activity Averx Drugs Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.
Averx Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Vijayawada. was recorded as a recent event.
The activity Nagasekhar Ramineni was appointed as a Managing Director was appointed as a Managing Director on 27 Mar 2019 & has been associated with this company since 6 years 8 months . was completed.
Progress on A charge with Others amounted to Rs. 2.13 Cr with Charge ID 100202612 was registered on 05 Sep 2018. was documented.
A charge with Others amounted to Rs. 5.35 Cr with Charge ID 100047169 was registered on 31 Aug 2016. was recorded as a recent event.
The CIN of Averx Drugs Private Limited is U24100AP2014PTC095163.
Averx Drugs Private Limited is headquartered at Plot No 27A, 32A And 27A31 Denotified Area, Lalamkoduru, Rambilli, Atchuthapuram, Paravada, Andhra Pradesh, 531019.
Averx Drugs Private Limited was incorporated on 26 August 2014.
The current directors of Averx Drugs Private Limited are
The primary industry of Averx Drugs Private Limited is Manufacturing.
Averx Drugs Private Limited is unlisted.
The authorized capital of Averx Drugs Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.91 Cr.
The compliance status of Averx Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX